Molecular profile and clinical impact of MDM2 amplification in patients with advanced biliary tract cancer.

ESMO Open · 2025 · PMC12335989 · PMID 40743751

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

For OS, MDM2 -amp/ TP53 -WT status showed a trend toward favorable survival; however, the result was not statistically significant (HR 0.70, 95% CI 0.48-1.02, P = 0.065) ( Table 2 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.